You have 9 free searches left this month | to do more
Showing 1 - 25 of
7,322 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19
Withdrawn
  • COVID-19
  • BRII-196 and BRII-198
  • Placebo
  • Hong Kong, China
    Investigative Site 1
2022-03-01
Mar 1, 2022
B
A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 - 2021
Completed
  • COVID-19
  • BRII-196 and BRII-198
  • Placebo
  • Beijing, Beijing, China
    Investigative Site
2022-03-01
Mar 1, 2022
B
A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 - 2021
Completed
  • COVID-19
  • BRII-196 and BRII-198
  • Placebo
  • Beijing, Beijing, China
  • +5 more
2022-03-01
Mar 1, 2022
N
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants - 2021
Completed
Has Results
  • HIV Infections
  • VRC01
  • +2 more
  • Los Angeles, California
  • +13 more
2022-03-24
Mar 24, 2022
L
Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer - 2002
Terminated
Has Results
  • Ovarian Cancer
  • Monoclonal antibody hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-07-20
Jul 20, 2021
F
FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Not yet recruiting
  • Solid Tumor, Adult
  • (no location specified)
2021-10-01
Oct 1, 2021
M
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma - 2022
Completed
  • Neuroblastoma
  • beta-glucan
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-03-04
Mar 4, 2022
G
Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
Active, not recruiting
  • Metastatic Colon Cancer
  • Alcoy, Alicante, Spain
  • +47 more
2022-03-15
Mar 15, 2022
M
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-30
Mar 30, 2022
M
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-10-28
Oct 28, 2021
L
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer - 2006
Completed
Has Results
  • Ovarian Cancer
  • 90Y-hu3S193
  • 111In-hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-11-23
Nov 23, 2021
E
VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer
Active, not recruiting
  • Colon Carcinoma Metastatic in the Liver
  • +13 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +3 more
  • Atlanta, Georgia
  • +3 more
2021-12-15
Dec 15, 2021
Z
Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies
Not yet recruiting
  • Hematological Malignancies
  • NK cells/Combined Monoclonal Antibodies
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
2020-12-08
Dec 8, 2020
L
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer - 2002
Terminated
Has Results
  • Colorectal Cancer
  • monoclonal antibody hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-07-15
Jul 15, 2021
M
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
Recruiting
  • CD30-Positive Neoplastic Cells Present
  • Malignant Mesothelioma
  • Brentuximab Vedotin
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-03
Jan 3, 2022
M
Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease
Recruiting
  • Adult Acute Lymphoblastic Leukemia in Complete Remission
  • +3 more
  • Blinatumomab
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
2021-09-22
Sep 22, 2021
N
The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV - 1996
Completed
  • HIV Infections
  • F105 Monoclonal Antibody (Human)
  • Boston, Massachusetts
    Beth Israel Deaconess Med. Ctr., ACTG CRS
2021-10-28
Oct 28, 2021
W
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Active, not recruiting
  • Human Papillomavirus Infection
  • +11 more
  • Durvalumab
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
2021-12-17
Dec 17, 2021
M
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma - 2021
Completed
  • Neuroblastoma
  • anti-GD2 murine IgG3 monoclonal antibody 3F8
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-01-26
Jan 26, 2021
J
Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma - 2021
Terminated
  • Metastatic Melanoma
  • +5 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +4 more
  • Los Angeles, California
  • +1 more
2021-04-01
Apr 1, 2021
L
Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC) - 2006
Completed
Has Results
  • Lung Cancer
  • monoclonal antibody hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2022-02-07
Feb 7, 2022
Y
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +2 more
  • Iodine I 131 MOAB 8H9
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-02-07
Feb 7, 2022
F
Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies - 2018
Terminated
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +32 more
  • indium In 111 anti-CD45 monoclonal antibody BC8
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
2021-03-07
Mar 7, 2021
B
Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV
Enrolling by invitation
  • PTLD
  • +2 more
  • low-dose CD20 monoclonal antibody injection
  • Beijing, Beijing, China
    Beijing Friendship Hospital
2022-02-24
Feb 24, 2022
U
Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma
Recruiting
  • Non-Hodgkin Lymphoma
  • +7 more
  • Mosunetuzumab
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-28
Mar 28, 2022